Minapharm Pharmaceuticals
Minapharm Pharmaceuticals operates in various business sectors.
Market Cap & Net Worth: Minapharm Pharmaceuticals (MIPH)
Minapharm Pharmaceuticals (EGX:MIPH) has a market capitalization of $93.91K (EGP4.75 Million) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #41355 globally and #6 in its home market, demonstrating a 3.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Minapharm Pharmaceuticals's stock price EGP476.28 by its total outstanding shares 9969 (9.97K).
Minapharm Pharmaceuticals Market Cap History: 2015 to 2026
Minapharm Pharmaceuticals's market capitalization history from 2015 to 2026. Data shows growth from $3.86K to $93.91K (33.72% CAGR).
Minapharm Pharmaceuticals Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Minapharm Pharmaceuticals's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MIPH by Market Capitalization
Companies near Minapharm Pharmaceuticals in the global market cap rankings as of March 18, 2026.
Key companies related to Minapharm Pharmaceuticals by market ranking:
- Cannabics Pharmaceuticals Inc (PINK:CNBX): Ranked #41346 globally with a market cap of $87.08K USD.
- Archos (PA:ALJXR): Ranked #41347 globally with a market cap of $87.06K USD ( €84.81K EUR).
- Goliath Film and Media Holdings (PINK:GFMH): Ranked #41356 globally with a market cap of $86.45K USD.
- Fonu2 Inc (PINK:FONU): Ranked #41357 globally with a market cap of $86.42K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41346 | Cannabics Pharmaceuticals Inc | PINK:CNBX | $87.08K | $0.01 |
| #41347 | Archos | PA:ALJXR | $87.06K | €0.21 |
| #41356 | Goliath Film and Media Holdings | PINK:GFMH | $86.45K | $0.00 |
| #41357 | Fonu2 Inc | PINK:FONU | $86.42K | $0.00 |
Minapharm Pharmaceuticals Historical Marketcap From 2015 to 2026
Between 2015 and today, Minapharm Pharmaceuticals's market cap moved from $3.86K to $ 93.91K, with a yearly change of 33.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP93.91K | +36.39% |
| 2025 | EGP68.85K | +115.08% |
| 2024 | EGP32.01K | -25.41% |
| 2023 | EGP42.92K | +46.87% |
| 2022 | EGP29.22K | +39.82% |
| 2021 | EGP20.90K | +32.02% |
| 2020 | EGP15.83K | -5.49% |
| 2019 | EGP16.75K | -3.47% |
| 2018 | EGP17.35K | +39.08% |
| 2017 | EGP12.48K | +22.11% |
| 2016 | EGP10.22K | +164.59% |
| 2015 | EGP3.86K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Minapharm Pharmaceuticals was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $93.91K USD |
| MoneyControl | $93.91K USD |
| MarketWatch | $93.91K USD |
| marketcap.company | $93.91K USD |
| Reuters | $93.91K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.